# A Study of Ivonescimab in People With Leiomyosarcoma

> **NCT07516925** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 20 (estimated)

## Conditions studied

- Leiomyosarcoma

## Interventions

- **DRUG:** Ivonescimab

## Key facts

- **NCT ID:** NCT07516925
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-04
- **Final completion:** 2029-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516925, "A Study of Ivonescimab in People With Leiomyosarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07516925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*